Dr. Coffey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 NW 14th Street
Miami, FL 33136
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of ColoradoResidency, Internal Medicine, 2009 - 2012
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2009, MD
- Tulane UniversityBS, Biology, 1999 - 2003
Certifications & Licensure
- FL State Medical License 2021 - 2026
- WA State Medical License 2012 - 2022
- CO State Medical License 2009 - 2012
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 405 citationsDiagnosis and Management of Multiple Myeloma: A Review.Andrew J Cowan, Damian J Green, Mary Kwok, Sarah Lee, David G Coffey
JAMA. 2022-02-01 - 68 citationsCD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma.Cristan M. Jubala, John Wojcieszyn, Victor E. Valli, David M. Getzy, Susan Fosmire
Veterinary Pathology. 2005-07-01 - 25 citationsγ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, ...Andrew J Cowan, Margot J Pont, Blythe D Sather, Cameron J Turtle, Brian G Till
The Lancet. Oncology. 2023-07-01
Journal Articles
- FAS ligand gene transfer for cancer therapyJaime F Modiano, Angela R Lamerato-Kozicki, CM Jubala, David G Coffey, Michelle Borakove, Jerome Schaack, and Donald Bellgrau, Cancer Therapy
Abstracts/Posters
- Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...David G. Coffey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Targeted Next Generation Sequencing of Circulating Tumor DNA in Multiple MyelomaCoffey DG, Orneals S, Towlerton AMH, Warren EH, Blood 2017 130:4337, American Society of Hematology Annual Meeting, 2017
- Simultaneous Detection Of Single Nucleotide Variants, mRNA Transcripts, And Protein Expression In Myeloma Bone Marrow AspiratesCoffey DG, Lombardo KA, Towlerton AMH, Farwell MA, Meredith G, Meredith R, Green DJ, Warren EH, Blood 2017 130:1758, American Society of Hematology Annual Meeting, 2017
- Join now to see all
Lectures
- High-Throughput Functional Drug Screening and Genomic Analysis to Guide Individualized Therapy for Relapsed/Refractory Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Reduced Antigen Presentation May Contribute to Immunomodulatory Drug Resistance in Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
- Sylvester Pursues Landmark Research Presented at International Hematology ConferenceJanuary 30th, 2023
Grant Support
- Data Generation and Bioinformatics Support GrantSeattle Translational Tumor Research2019–2020
- Catalytic Collaboration Pilot AwardBrotman Baty Institute2019
- Research Training Award for FellowsAmerican Society of Hematology2015–2016
- T32 FellowshipNational, Heart, Lung and Blood Institute2014–2015
Professional Memberships
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: